{"organizations": [], "uuid": "fbb6f086c553bd64e41a48bc5b0ec4db5ff196f6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-beigene-presents-clinical-data-on/brief-beigene-presents-clinical-data-on-pamiparib-in-chinese-patients-with-ovarian-cancers-at-the-american-association-for-cancer-research-annual-meeting-idUSFWN1RT0N6", "country": "US", "domain_rank": 408, "title": "BRIEF-Beigene Presents Clinical Data On Pamiparib In Chinese Patients With Ovarian Cancers At The American Association For Cancer Research Annual Meeting", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-16T16:29:00.000+03:00", "replies_count": 0, "uuid": "fbb6f086c553bd64e41a48bc5b0ec4db5ff196f6"}, "author": "", "url": "https://www.reuters.com/article/brief-beigene-presents-clinical-data-on/brief-beigene-presents-clinical-data-on-pamiparib-in-chinese-patients-with-ovarian-cancers-at-the-american-association-for-cancer-research-annual-meeting-idUSFWN1RT0N6", "ord_in_thread": 0, "title": "BRIEF-Beigene Presents Clinical Data On Pamiparib In Chinese Patients With Ovarian Cancers At The American Association For Cancer Research Annual Meeting", "locations": [], "entities": {"persons": [{"name": "pamiparib", "sentiment": "none"}], "locations": [{"name": "china", "sentiment": "none"}], "organizations": [{"name": "american association for cancer research annual", "sentiment": "none"}, {"name": "beigene ltd", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "the american association for cancer research annual meeting reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Market News April 16, 2018 / 1:31 PM / Updated 6 minutes ago BRIEF-Beigene Presents Clinical Data On Pamiparib In Chinese Patients With Ovarian Cancers At The American Association For Cancer Research Annual Meeting Reuters Staff 1 Min Read \nApril 16 (Reuters) - Beigene Ltd: \n* BEIGENE PRESENTS CLINICAL DATA ON PAMIPARIB IN CHINESE PATIENTS WITH OVARIAN CANCERS OR TRIPLE-NEGATIVE BREAST CANCER AT THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL MEETING \n* BEIGENE LTD - PAMIPARIB WAS SHOWN TO BE GENERALLY WELL TOLERATED \n* BEIGENE LTD - LOOK FORWARD TO ADVANCING PAMIPARIBâ€™S DEVELOPMENT IN CHINA AS WELL AS INITIATING A GLOBAL PHASE 3 TRIAL \n* BEIGENE - IN PATIENTS WITH OVARIAN, BREAST CANCER, PRELIM RESULTS SUPPORT RECOMMENDED PAMIPARIB DOSING REGIMEN, DEMONSTRATED ANTITUMOR ACTIVITY \n* BEIGENE-SAW NO DOSE-LIMITING TOXICITIES, FOUND PAMIPARIB TO BE GENERALLY WELL TOLERATED AMONG THE PRE-TREATED PATIENTS WITH OVARIAN, BREAST CANCERS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-16T16:29:00.000+03:00", "crawled": "2018-04-16T16:43:39.022+03:00", "highlightTitle": ""}